Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate
Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS 4) to the gastrin-rele...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2008-04, Vol.18 (7), p.2424-2427 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2427 |
---|---|
container_issue | 7 |
container_start_page | 2424 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 18 |
creator | Dubuc, Céléna Langlois, Réjean Bénard, François Cauchon, Nicole Klarskov, Klaus Tone, Paul van Lier, Johan E. |
description | Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS
4) to the gastrin-releasing peptide receptor (GRPR) through coupling to bombesin. A mono-carbohexyl derivative of AlPcS
4 is attached to 8-Aoc-bombesin(7–14)NH
2 via an amide bridge to yield a bombesin–AlPcS
4 conjugate linked by a C-14 spacer chain. The conjugate is characterized by mass spectroscopy and shown to bind to the GRPR with a relative binding affinity (RBA) of 2.3, taking bombesin (RBA
=
100) as unity. The in vitro photodynamic efficacy of the conjugate against PC-3 human prostate cancer cells is improved by a factor 2.5 over the non-conjugated mono-carbohexyl derivative of AlPcS
4. |
doi_str_mv | 10.1016/j.bmcl.2008.02.051 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70465592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X08002321</els_id><sourcerecordid>70465592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-b83cc3ddba53e67ded12a8b168167f51df3794750a1d1cff0b850a4cd3f6f0573</originalsourceid><addsrcrecordid>eNqFkbuO1DAUhi0EYoeFF6BAbqBL8DUXiQatWEBaiWaR6CzHPp7xKImD7Vk0HTUtb8iTrMOMoIPKR_bnY5__Q-g5JTUltHm9r4fJjDUjpKsJq4mkD9CGikZUXBD5EG1I35Cq68WXC_QkpT0hVBAhHqML2nHWs6bboB-3Om4h-3mLtzrl6Ocqwgg6rTsLLNlbwBFMqUJMODi8xJCyzoCNng1EbGAcE3Yh4mUXcrDHWU_e4LyDqJcj_ubzDutylnd6DOaoZz_Dr-8_hzANUF7BJsz7w7Y0fIoeOT0meHZeL9Hn63e3Vx-qm0_vP169vamMoDJXQ8eN4dYOWnJoWguWMt0NtOlo0zpJreNtL1pJNLXUOEeGrtTCWO4aR2TLL9GrU98yydcDpKwmn9Yp9AzhkFRLRCNlz_4L0r6k2HNaQHYCTckmRXBqiX7S8agoUasqtVerKrWqUoSpoqpcenHufhgmsH-vnN0U4OUZ0Mno0cWSt09_OEaY5PL3PG9OHJTQ7jxElYyH4sb6Ii4rG_y__nEPmhu3MQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19329931</pqid></control><display><type>article</type><title>Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dubuc, Céléna ; Langlois, Réjean ; Bénard, François ; Cauchon, Nicole ; Klarskov, Klaus ; Tone, Paul ; van Lier, Johan E.</creator><creatorcontrib>Dubuc, Céléna ; Langlois, Réjean ; Bénard, François ; Cauchon, Nicole ; Klarskov, Klaus ; Tone, Paul ; van Lier, Johan E.</creatorcontrib><description>Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS
4) to the gastrin-releasing peptide receptor (GRPR) through coupling to bombesin. A mono-carbohexyl derivative of AlPcS
4 is attached to 8-Aoc-bombesin(7–14)NH
2 via an amide bridge to yield a bombesin–AlPcS
4 conjugate linked by a C-14 spacer chain. The conjugate is characterized by mass spectroscopy and shown to bind to the GRPR with a relative binding affinity (RBA) of 2.3, taking bombesin (RBA
=
100) as unity. The in vitro photodynamic efficacy of the conjugate against PC-3 human prostate cancer cells is improved by a factor 2.5 over the non-conjugated mono-carbohexyl derivative of AlPcS
4.</description><identifier>ISSN: 0960-894X</identifier><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3405</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmcl.2008.02.051</identifier><identifier>PMID: 18329268</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Binding Sites ; Biological and medical sciences ; Bombesin - chemistry ; Bombesin - pharmacology ; Bombesin conjugate ; Cell Line, Tumor ; Drug Delivery Systems - methods ; Humans ; Indoles - chemical synthesis ; Indoles - pharmacology ; Indoles - therapeutic use ; Male ; Mass Spectrometry ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Organometallic Compounds - chemical synthesis ; Organometallic Compounds - pharmacology ; Organometallic Compounds - therapeutic use ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Photochemotherapy ; Photodynamic therapy ; Photosensitizing Agents - chemical synthesis ; Photosensitizing Agents - pharmacology ; Photosensitizing Agents - therapeutic use ; Prostatic Neoplasms - drug therapy ; Prostatic Neoplasms - pathology ; Receptors, Bombesin - metabolism ; Sulfonated phthalocyanines</subject><ispartof>Bioorganic & medicinal chemistry, 2008-04, Vol.18 (7), p.2424-2427</ispartof><rights>2008 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-b83cc3ddba53e67ded12a8b168167f51df3794750a1d1cff0b850a4cd3f6f0573</citedby><cites>FETCH-LOGICAL-c415t-b83cc3ddba53e67ded12a8b168167f51df3794750a1d1cff0b850a4cd3f6f0573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X08002321$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20253557$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18329268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubuc, Céléna</creatorcontrib><creatorcontrib>Langlois, Réjean</creatorcontrib><creatorcontrib>Bénard, François</creatorcontrib><creatorcontrib>Cauchon, Nicole</creatorcontrib><creatorcontrib>Klarskov, Klaus</creatorcontrib><creatorcontrib>Tone, Paul</creatorcontrib><creatorcontrib>van Lier, Johan E.</creatorcontrib><title>Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS
4) to the gastrin-releasing peptide receptor (GRPR) through coupling to bombesin. A mono-carbohexyl derivative of AlPcS
4 is attached to 8-Aoc-bombesin(7–14)NH
2 via an amide bridge to yield a bombesin–AlPcS
4 conjugate linked by a C-14 spacer chain. The conjugate is characterized by mass spectroscopy and shown to bind to the GRPR with a relative binding affinity (RBA) of 2.3, taking bombesin (RBA
=
100) as unity. The in vitro photodynamic efficacy of the conjugate against PC-3 human prostate cancer cells is improved by a factor 2.5 over the non-conjugated mono-carbohexyl derivative of AlPcS
4.</description><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Bombesin - chemistry</subject><subject>Bombesin - pharmacology</subject><subject>Bombesin conjugate</subject><subject>Cell Line, Tumor</subject><subject>Drug Delivery Systems - methods</subject><subject>Humans</subject><subject>Indoles - chemical synthesis</subject><subject>Indoles - pharmacology</subject><subject>Indoles - therapeutic use</subject><subject>Male</subject><subject>Mass Spectrometry</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Organometallic Compounds - chemical synthesis</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Organometallic Compounds - therapeutic use</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Photochemotherapy</subject><subject>Photodynamic therapy</subject><subject>Photosensitizing Agents - chemical synthesis</subject><subject>Photosensitizing Agents - pharmacology</subject><subject>Photosensitizing Agents - therapeutic use</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Receptors, Bombesin - metabolism</subject><subject>Sulfonated phthalocyanines</subject><issn>0960-894X</issn><issn>0968-0896</issn><issn>1464-3405</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkbuO1DAUhi0EYoeFF6BAbqBL8DUXiQatWEBaiWaR6CzHPp7xKImD7Vk0HTUtb8iTrMOMoIPKR_bnY5__Q-g5JTUltHm9r4fJjDUjpKsJq4mkD9CGikZUXBD5EG1I35Cq68WXC_QkpT0hVBAhHqML2nHWs6bboB-3Om4h-3mLtzrl6Ocqwgg6rTsLLNlbwBFMqUJMODi8xJCyzoCNng1EbGAcE3Yh4mUXcrDHWU_e4LyDqJcj_ubzDutylnd6DOaoZz_Dr-8_hzANUF7BJsz7w7Y0fIoeOT0meHZeL9Hn63e3Vx-qm0_vP169vamMoDJXQ8eN4dYOWnJoWguWMt0NtOlo0zpJreNtL1pJNLXUOEeGrtTCWO4aR2TLL9GrU98yydcDpKwmn9Yp9AzhkFRLRCNlz_4L0r6k2HNaQHYCTckmRXBqiX7S8agoUasqtVerKrWqUoSpoqpcenHufhgmsH-vnN0U4OUZ0Mno0cWSt09_OEaY5PL3PG9OHJTQ7jxElYyH4sb6Ii4rG_y__nEPmhu3MQ</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Dubuc, Céléna</creator><creator>Langlois, Réjean</creator><creator>Bénard, François</creator><creator>Cauchon, Nicole</creator><creator>Klarskov, Klaus</creator><creator>Tone, Paul</creator><creator>van Lier, Johan E.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20080401</creationdate><title>Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate</title><author>Dubuc, Céléna ; Langlois, Réjean ; Bénard, François ; Cauchon, Nicole ; Klarskov, Klaus ; Tone, Paul ; van Lier, Johan E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-b83cc3ddba53e67ded12a8b168167f51df3794750a1d1cff0b850a4cd3f6f0573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Bombesin - chemistry</topic><topic>Bombesin - pharmacology</topic><topic>Bombesin conjugate</topic><topic>Cell Line, Tumor</topic><topic>Drug Delivery Systems - methods</topic><topic>Humans</topic><topic>Indoles - chemical synthesis</topic><topic>Indoles - pharmacology</topic><topic>Indoles - therapeutic use</topic><topic>Male</topic><topic>Mass Spectrometry</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Organometallic Compounds - chemical synthesis</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Organometallic Compounds - therapeutic use</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Photochemotherapy</topic><topic>Photodynamic therapy</topic><topic>Photosensitizing Agents - chemical synthesis</topic><topic>Photosensitizing Agents - pharmacology</topic><topic>Photosensitizing Agents - therapeutic use</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Receptors, Bombesin - metabolism</topic><topic>Sulfonated phthalocyanines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubuc, Céléna</creatorcontrib><creatorcontrib>Langlois, Réjean</creatorcontrib><creatorcontrib>Bénard, François</creatorcontrib><creatorcontrib>Cauchon, Nicole</creatorcontrib><creatorcontrib>Klarskov, Klaus</creatorcontrib><creatorcontrib>Tone, Paul</creatorcontrib><creatorcontrib>van Lier, Johan E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubuc, Céléna</au><au>Langlois, Réjean</au><au>Bénard, François</au><au>Cauchon, Nicole</au><au>Klarskov, Klaus</au><au>Tone, Paul</au><au>van Lier, Johan E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>18</volume><issue>7</issue><spage>2424</spage><epage>2427</epage><pages>2424-2427</pages><issn>0960-894X</issn><issn>0968-0896</issn><eissn>1464-3405</eissn><eissn>1464-3391</eissn><abstract>Sulfonated aluminum phthalocyanines (AlPcS) are potent photosensitizers for the photodynamic therapy (PDT) of cancer. In this study we evaluate the possibility to improve the efficacy of AlPcS-PDT for prostate cancer by targeting tetrasulfonated aluminum phthalocyanines (AlPcS
4) to the gastrin-releasing peptide receptor (GRPR) through coupling to bombesin. A mono-carbohexyl derivative of AlPcS
4 is attached to 8-Aoc-bombesin(7–14)NH
2 via an amide bridge to yield a bombesin–AlPcS
4 conjugate linked by a C-14 spacer chain. The conjugate is characterized by mass spectroscopy and shown to bind to the GRPR with a relative binding affinity (RBA) of 2.3, taking bombesin (RBA
=
100) as unity. The in vitro photodynamic efficacy of the conjugate against PC-3 human prostate cancer cells is improved by a factor 2.5 over the non-conjugated mono-carbohexyl derivative of AlPcS
4.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>18329268</pmid><doi>10.1016/j.bmcl.2008.02.051</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry, 2008-04, Vol.18 (7), p.2424-2427 |
issn | 0960-894X 0968-0896 1464-3405 1464-3391 |
language | eng |
recordid | cdi_proquest_miscellaneous_70465592 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Binding Sites Biological and medical sciences Bombesin - chemistry Bombesin - pharmacology Bombesin conjugate Cell Line, Tumor Drug Delivery Systems - methods Humans Indoles - chemical synthesis Indoles - pharmacology Indoles - therapeutic use Male Mass Spectrometry Medical sciences Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Organometallic Compounds - chemical synthesis Organometallic Compounds - pharmacology Organometallic Compounds - therapeutic use Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems Pharmacology. Drug treatments Photochemotherapy Photodynamic therapy Photosensitizing Agents - chemical synthesis Photosensitizing Agents - pharmacology Photosensitizing Agents - therapeutic use Prostatic Neoplasms - drug therapy Prostatic Neoplasms - pathology Receptors, Bombesin - metabolism Sulfonated phthalocyanines |
title | Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A51%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20gastrin-releasing%20peptide%20receptors%20of%20prostate%20cancer%20cells%20for%20photodynamic%20therapy%20with%20a%20phthalocyanine%E2%80%93bombesin%20conjugate&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Dubuc,%20C%C3%A9l%C3%A9na&rft.date=2008-04-01&rft.volume=18&rft.issue=7&rft.spage=2424&rft.epage=2427&rft.pages=2424-2427&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2008.02.051&rft_dat=%3Cproquest_cross%3E70465592%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19329931&rft_id=info:pmid/18329268&rft_els_id=S0960894X08002321&rfr_iscdi=true |